[#DIV28SUPER] New SPARC Funding Opportunity

 

 

SPARC Funding Opportunity Announcement: RFA-RM-22-002: SPARC VNS Endpoints from Standardized Parameters (U54 Clinical Trial Required) 

 

The NIH Common Fund's Stimulating Peripheral Activity to Relieve Conditions (SPARC) program aims to accelerate development of therapeutic devices that modulate electrical activity in nerves to improve organ function. In December 2021, NIH announced a new SPARC Funding Opportunity: RFA-RM-22-002: SPARC VNS Endpoints from Standardized Parameters to support a large multisite study of the multi-organ effects of vagus nerve stimulation (VNS) in humans. The SPARC VNS Endpoints from Standardized Parameters Center will implement a common study protocol of direct stimulation of the cervical vagus nerve in participants with implanted VNS devices and will document and analyze the physiological outcomes from at least three peripheral physiological systems. The data from this study will help inform the optimization of VNS treatment by providing key information on the functional connectivity of the human vagus nerve.  

 

Funding Opportunity Announcement 

RFA-RM-22-002: SPARC VNS Endpoints from Standardized Parameters 

 

Save the Dates 

Check the SPARC Scientific Meetings webpage for registration links (coming soon) 

• Informational Webinars:  
• January 21, 2022 at 4:00pm ET 
• February 2, 2022 at 3:00pm ET 
• Team-Building Webinar: February 18, 2022 at 3:00pm ET 

 

Important Dates 

• Letter of Intent Due Date: March 1, 2022 (not required, but strongly encouraged) 
• Application Due Date: April 1, 2022 by 5:00pm local time of applicant organization 

 

You can find answers to Frequently Asked Questions (FAQs) and learn more about the program on the SPARC website. We also encourage you to sign up for the SPARC listserv to keep up to date with the latest SPARC news and information. 

 

Please share this information widely with interested colleagues and relevant email lists. 

 

NIH SPARC Team 

 

Email: sparc-v@od.nih.gov  

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L